Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank

Regulatory Peptides

Volumn 170, Issue 1-3, 2011, Pages 18-23

  Kolomin, Timur ^a   Shadrina, Maria ^a   Andreeva, Lyudmila ^a   Slominsky, Petr ^a   Limborska, Svetlana ^a   Myasoedov, Nikolay ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

Author keywords

Bcl6 gene; Endogenous regulatory peptides; Inflammation; Selank; TP 7; Transcriptome

Indexed keywords

CHEMOKINE; CYTOKINE; PEPTIDE FRAGMENT; PROTEIN BCL 6; RECEPTOR; SELANK; TUFTSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BCL6 GENE; BCOR GENE; CCND1 GENE; CCND2 GENE; CD44 GENE; CD69 GENE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GENE; GENE EXPRESSION; INFLAMMATION; MOLECULAR DYNAMICS; MOUSE; NCOR1 GENE; NCOR2 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SPLEEN; STAT1 GENE;

ANIMALS; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; IMMUNOLOGIC FACTORS; MALE; MICE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; SPLEEN; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 79959723723     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.05.001     Document Type: Article

References (35)

1. Najjar V.A., Nishioka K. "Tuftsin": a natural phagocytosis stimulating peptide. Nature 1970, 228(5272):672-673.
2. Siemion I.Z., Kluczyk A., Cebrat M. The peptide molecular links between the central nervous and the immune systems. Amino Acids 2005, 29(3):161-176.
3. Dzierzbicka K., Trzonkowski P., Sewerynek P., Kolodziejczyk A.M., Mysliwski A. Synthesis and biological activity of tuftsin, its analogue and conjugates containing muramyl dipeptides or nor-muramyl dipeptides. J Pept Sci 2005, 11(3):123-135.
4. Khan A., Khan A.A., Dwivedi V., Ahmad M.G., Hakeem S., Owais M. Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice. Mol Med 2007, 13(5-6):266-276.
5. Ashmarin I.P., Samonina G.E., Lyapina L.A., Kamenskii A.A., Levitskaya N.G., Grivennikov I.A., et al. Natural and hybrid ("chimeric") stable regulatory glyproline peptides. Pathophysiology 2005, 11(4):179-185.
6. Ashmarin I.P. Glyprolines in regulatory tripeptides. Neurochem J 2007, 1(3):173-175.
7. Kozlovskaya M.M., Kozlovskii I.I., Val'dman E.A., Seredenin S.B. Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress. Neurosci Behav Physiol 2003, 33(9):853-860.
8. Bulatova N.R., Romanova E.A., Krinskaia A.V., Sarychev E.I., Val'dman A.V. Post-stress correlation of the functional activity of macrophages by tuftsin and its derivatives. Biull Eksp Biol Med 1989, 108(7):64-67.
9. Czabak-Garbacz R., Cygan B., Wolanski L., Kozlovsky I. Influence of long-term treatment with tuftsin analogue TP-7 on the anxiety-phobic states and body weight. Pharmacol Rep 2006, 58(4):562-567.
10. Zozulya A.A., Kost N.V., Yu Sokolov O., Gabaeva M.V., Grivennikov I.A., Andreeva L.N., et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bull Exp Biol Med 2001, 131(4):315-317.
11. Sollertinskaya T.N., Shorokhov M.V., Kozlovskaya M.M., Kozlovskii I.I., Sudakov K.V. Compensatory and antiamnestic effects of heptapeptide Selank in monkeys. Zh Evol Biokhim Fiziol 2008, 44(3):284-290.
12. Semenova T.P., Kozlovskaya M.M., Zuikov A.V., Kozlovskii I.I., Zakharova N.M., Andreeva L.A. Use of Selank to correct measures of integrative brain activity and biogenic amine levels in adult rats resulting from antenatal hypoxia. Neurosci Behav Physiol 2008, 38(2):203-207.
13. Shevchenko V.P., Nagaev I.Y., Alfeeva L.Y., Andreeva L.A., Shevchenko K.V., Myasoedov N.F. Synthesis of tritium-labeled Selank. Radiochemistry 2006, 48(3):196-200.
14. Zolotarev Iu A., Sokolov O., Kost N.V., Vas'kovskii B.V., Miasoedov N.F., Zozulia A.A. Leu-enkephalin homogeneously labeled with tritium in studying the Selank inhibiting effect on the enkephalin-degrading enzymes of human plasma. Bioorg Khim 2004, 30(3):234-240.
15. Kost N.V., Sokolov O., Gabaeva M.V., Grivennikov I.A., Andreeva L.A., Miasoedov N.F., et al. Semax and Selank inhibit the enkephalin-degrading enzymes from human serum. Bioorg Khim 2001, 27(3):180-183.
16. Zozulya A.A., Gabaeva M.V., Sokolov O.Y., Surkina I.D., Kost N.V. Personality, coping style, and constitutional neuroimmunology. J Immunotoxicol 2008, 5(2):221-225.
17. Kozlovskii I.I., Danchev N.D. The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats. Neurosci Behav Physiol 2003, 33(7):639-643.
18. Ershov F.I., Uchakin P.N., Uchakina O.N., Mezentseva M.V., Alekseeva L.A., Miasoedov N.F. Antiviral activity of immunomodulator Selank in experimental influenza infection. Vopr Virusol 2009, 54(5):19-24.
19. Andreeva L.A., Nagaev I.Y., Mezentseva M.V., Shapoval I.M., Podchernyaeva R.Y., Shcherbenko V.E., et al. Antiviral properties of structural fragments of the peptide Selank. Dokl Biol Sci 2010, 431:79-82.
20. Kolomin T.A., Shadrina M.I., Agniullin Y.V., Shram S.I., Slominskii P.A., Limborska S.A., et al. Transcriptomic response of rat hippocampus and spleen cells to single and chronic administration of the peptide Selank. Dokl Biochem Biophys 2010, 430:5-6.
21. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45.
22. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30(9):e36.
23. Pfaffl M.W., Tichopad A., Prgomet C., Neuvians T.P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 2004, 26(6):509-515.
24. Jardin F., Ruminy P., Bastard C., Tilly H. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis. Pathol Biol (Paris) 2007, 55(1):73-83.
25. Yamazaki C., Miyamoto R., Hoshino K., Fukuda Y., Sasaki I., Saito M., et al. Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice. Biochem Biophys Res Commun 2010, 397(4):756-761.
26. Asao H. Analysis of gammac-dependent cytokines-mediated immunoregulation. Rinsho Byori 2007, 55(1):51-58.
27. Dhordain P., Albagli O., Ansieau S., Koken M.H., Deweindt C., Quief S., et al. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo. Oncogene 1995, 11(12):2689-2697.
28. Dent A.L., Shaffer A.L., Yu X., Allman D., Staudt L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997, 276(5312):589-592.
29. Fukuda T., Yoshida T., Okada S., Hatano M., Miki T., Ishibashi K., et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med 1997, 186(3):439-448.
30. Ye B.H., Cattoretti G., Shen Q., Zhang J., Hawe N., de Waard R., et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997, 16(2):161-170.
31. Bajalica-Lagercrantz S., Piehl F., Farnebo F., Larsson C., Lagercrantz J. Expression of the BCL6 gene in the pre- and postnatal mouse. Biochem Biophys Res Commun 1998, 247(2):357-360.
32. Baron B.W., Anastasi J., Thirman M.J., Furukawa Y., Fears S., Kim D.C., et al. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci U S A 2002, 99(5):2860-2865.
33. Shaffer A.L., Yu X., He Y., Boldrick J., Chan E.P., Staudt L.M. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000, 13(2):199-212.
34. Phan R.T., Saito M., Basso K., Niu H., Dalla-Favera R. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 2005, 6(10):1054-1060.
35. Ahmad K.F., Melnick A., Lax S., Bouchard D., Liu J., Kiang C.L., et al. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol Cell 2003, 12(6):1551-1564.